Earnings at Schering-Plough Climbed 75% in 4th Quarter - New York Times
January 29, 2007| Earnings at Schering-Plough Climbed 75% in 4th Quarter New York Times, NY - Sales of the anti-inflammatory drug Remicade, for disorders like rheumatoid arthritis and ulcerative colitis, jumped 34 percent, to $337 million, ... |
Schering-Plough 4Q profit up 75 percent - BusinessWeek
January 29, 2007 CNNMoney.com | Schering-Plough 4Q profit up 75 percent BusinessWeek - ... by a 34 percent rise in sales to $337 million for anti-inflammatory drug Remicade, for disorders such as rheumatoid arthritis and ulcerative colitis. ... Schering-Plough profit boosted by Remicade |
Drying time - Odessa American
January 29, 2007| Drying time Odessa American, TX - It also can be a sign of an underlying problem such as lupus, rheumatoid arthritis or Sjogren’s syndrome, a chronic disorder in which the immune system ... |
The Pittsburgh Life Sciences Greenhouse Announces Launch of ... - Drug Newswire (press release)
January 29, 2007| The Pittsburgh Life Sciences Greenhouse Announces Launch of ... Drug Newswire (press release), CT - The need for a more precise and consistent way to diagnose and plan treatment for inflammation caused by rheumatoid arthritis provided the springboard for ... |